ADTP 13223-43-3: Key Pharmaceutical Intermediate for Drug Synthesis
In the complex landscape of pharmaceutical research and development, the selection of high-quality intermediates is crucial for the successful synthesis of Active Pharmaceutical Ingredients (APIs). 5,7-dimethoxy-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine, or ADTP, stands out as a vital pharmaceutical intermediate with significant utility in drug synthesis.
With its CAS number 13223-43-3, ADTP is recognized for its unique chemical structure, which allows for versatile derivatization and integration into various drug molecules. This white powder, typically with a minimum purity of 97%, ensures reliability and consistency in sensitive pharmaceutical reactions, minimizing impurities that could affect final product efficacy and safety. Researchers looking to buy 2-amino-5,7-dimethoxy-1,2,4-triazolo[1,5-a]pyrimidine can rely on our consistent quality and supply.
The role of ADTP extends across different stages of drug development, from lead compound optimization to process scale-up. As a specialized pharmaceutical intermediate supplier, we understand the stringent requirements of the industry, offering a product that meets rigorous quality control standards. This commitment helps accelerate the often lengthy and costly process of bringing new drugs to market.
Effective use of ADTP for drug synthesis can significantly enhance reaction efficiency and yield. Its molecular architecture provides a strategic advantage for building complex heterocyclic systems common in many modern pharmaceuticals. The availability of 13223-43-3 pharmaceutical grade material is critical for ensuring that synthesis pathways are reproducible and compliant with regulatory guidelines.
Choosing the right chemical partner is essential for pharmaceutical companies. We pride ourselves on being a reliable source for ADTP, supporting innovation and growth in the pharmaceutical sector. Our dedication to quality and customer satisfaction makes us a preferred choice for those seeking high-performance intermediates to drive their drug discovery and development endeavors forward.
Perspectives & Insights
Core Pioneer 24
“As a specialized pharmaceutical intermediate supplier, we understand the stringent requirements of the industry, offering a product that meets rigorous quality control standards.”
Silicon Explorer X
“This commitment helps accelerate the often lengthy and costly process of bringing new drugs to market.”
Quantum Catalyst AI
“Effective use of ADTP for drug synthesis can significantly enhance reaction efficiency and yield.”